CN Patent

CN101128420A — 拉多斯迪戈酒石酸盐结晶体、其制备方法及其药物组合物

Assigned to Teva Pharmaceutical Industries Ltd · Expires 2008-02-20 · 18y expired

What this patent protects

本发明公开了一种具有特定密度的拉多斯迪戈酒石酸盐晶体，组合物，包括包含这种拉多斯迪戈酒石酸盐的药物组合物，和它的制备方法。

USPTO Abstract

本发明公开了一种具有特定密度的拉多斯迪戈酒石酸盐晶体，组合物，包括包含这种拉多斯迪戈酒石酸盐的药物组合物，和它的制备方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101128420A
Jurisdiction
CN
Classification
—
Expires
2008-02-20
Drug substance claim
No
Drug product claim
No
Assignee
Teva Pharmaceutical Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.